PepGen Inc. Files 8-K: Other Events & Financials
Ticker: PEPG · Form: 8-K · Filed: Dec 16, 2024 · CIK: 1835597
| Field | Detail |
|---|---|
| Company | Pepgen Inc. (PEPG) |
| Form Type | 8-K |
| Filed Date | Dec 16, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, financials
TL;DR
PepGen filed an 8-K on 12/16/24 for other events and financials.
AI Summary
PepGen Inc. filed an 8-K on December 16, 2024, reporting other events and financial statements. The company, incorporated in Delaware with its principal executive offices in Boston, MA, operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing provides an update on PepGen Inc.'s corporate activities and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine filing reporting standard corporate events and financial information, not indicating any immediate material changes or risks.
Key Numbers
- 001-41374 — SEC File Number (Identifies the company's filing history with the SEC.)
- 85-3819886 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- PepGen Inc. (company) — Registrant
- December 16, 2024 (date) — Date of Report
- Boston, Massachusetts (location) — Principal Executive Offices
- 2834 (industry_code) — Standard Industrial Classification
FAQ
What is the primary purpose of this 8-K filing for PepGen Inc.?
The 8-K filing on December 16, 2024, is for reporting 'Other Events' and 'Financial Statements and Exhibits'.
Where are PepGen Inc.'s principal executive offices located?
PepGen Inc.'s principal executive offices are located at 321 Harrison Avenue, 8th Floor, Boston, Massachusetts, 02118.
What is PepGen Inc.'s Standard Industrial Classification code?
PepGen Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
What is the SEC file number for PepGen Inc.?
PepGen Inc.'s SEC file number is 001-41374.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on December 16, 2024.
Filing Stats: 447 words · 2 min read · ~1 pages · Grade level 11.5 · Accepted 2024-12-16 08:00:08
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 per share PEPG Nasdaq Global Select
Filing Documents
- pepg-20241216.htm (8-K) — 39KB
- pepg-ex99_1.htm (EX-99.1) — 20KB
- 0000950170-24-136389.txt ( ) — 178KB
- pepg-20241216.xsd (EX-101.SCH) — 25KB
- pepg-20241216_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On December 16, 2024, PepGen Inc. announced that it received a clinical hold notice from the U.S. Food and Drug Administration (FDA) regarding its Investigational New Drug (IND) application to initiate the CONNECT2-EDO51 clinical trial in patients with Duchenne muscular dystrophy (DMD). A copy of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this form 8-K and incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release issued by PepGen Inc. on December 16, 2024 104 Cover Page Interactive Data File (embedded within Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PEPGEN INC> Date: December 16, 2024 By: /s/ Noel Donnelly Noel Donnelly, Chief Financial Officer